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FK506 is a immunosuppressive agent used in kidney and liver 
transplantation. After transplantation, kidney or liver 
usually starts hyperplasia or regeneration supported by 
cellular growth. The effects of FK506 on the growth of freshly 
isolated rat parenchymal hepatocytes or rabbit renal cortical 
tubular cells in culture were examined within a concentration 
range of 10µM. FK506 inhibited the DNA synthesis of 
cultured hepatocytes and renal tubular cells in a dose-
dependent manner. This was not due to increase of release of
the　 activated　 transforming　 growth　 factor一 β.The　 Cytotoxic
effect of FK506 on the cells was examined, but no significant
increase　 in　 the　 release　 of　 N-acetyl一 β,D-glucosaminidase
(NAG) from tubular cells or of glutamic oxaloacetic 
transaminase (GOT) from hepatocytes was observed. FK506 
at a non-cytotoxic concentration thus appears to directly 
inhibit the growth of cultured hepatocytes and tubular cells 
in vitro.
INTRODUCTION 
 FK506 is a potent immunosuppressive agent used for 
human organ transplantation to protect graft rejection 
reaction. FK506 has been isolated from a streptomyces'). 
At the time of removal of a donor kidney, transient 
ischemia occurs, causing acute tubular necrosis (ATN). 
The hepatocyte growth factor (HGF) may possibly be 
essential to the regeneration of tubular cells from ATN 2), 
A graft causes compensatory renal growth accompanied by 
transient tubular cell hyperplasia 3) . Transplanted liver 
also causes parenchymal hepatocyte regeneration. 
Following organ transplantation, patients must receive 
immunosuppressive therapy to avoid graft rejection. The 
effect of immunosuppressive agent on hyperplasia and 
regeneration of cells')-6) are little understood. The direct 
effects of FK506 on the growth of parenchymal 
hepatocytes and renal cortical tubular cells in a simple cell 
culture system were examined in this study.
MATERIALS AND METHODS 
Preparation of FK506 solution. 
 FK506 was kindly provided by Fujisawa Pharma-
ceuticals, Osaka, Japan. In 5 mM stock solution, FK506 
was dissolved in ethanol and it was diluted with culture 
medium when it was used for the assays. 
Preparation of HgCl2 solution. 
 HgCl2 (Wako Pure chemicals, Osaka, Japan) was dis-
solved in saline and 10-'M stock solution was prepared. At 
the time of use, stock solution was dilutd with culture 
medium. 
Isolation and culture of adult rat parenchymal 
hepatocytes. 
 The method has already been reported'). Parenchymay 
hepatocytes were isolated by in situ collagenase perfusion. 
Isolated hepatocytes contained few non-parenchymal cells 
and were cultured in serum-free Williams' E medium 
supplemented with 10-9 M insulin and 10-9 M dex-
amethasone, and 5 U/ml aprotinin. Cell density in DNA 
synthesis was 6.25 X 104 cells/em' and that for collecting 
the conditioned medium 1.25 X 10' cells/cm', respectively. 
Isolation and cultute of rabbit renal cortical tubular 
cells. 
 This was done as described previously'). Briefly, a 
homogenate of rabbit renal cortices was filtered through 
245 ,u m-pore and 105 u m-pore nylon meshes. Remnant 
tubular fragments on the latter mesh, which contained few 
glomeruli, were cultured in collagen-coated culture dishes 
in basal medium (a 50:50 mixture of Dulbecco's modified 
Eagle's medium and Ham's F-12 medium containing 20 ng/ 
ml piperacillin and 5 U/ml aprotinin) supplemented with 
10-'M insulin, 10-'M dexamethasone, and 5 ,u g/ml bovine 
transferrin. The tubular cells contained few glomerular 
cells or fibroblasts.
Assay of the DNA synthesis of rat hepatocytes and rabbit 
renal cortical tubular cells. 
 Assays of the DNA synthesis of cultured rat 
parenchymal hepatocytes and rabbit renal cortical tubular 
cells were conducted as described previously')'). After 
preparation of the cells, the samples were added with 
serum- and hormone-free medium to the cells and 16 h (for 
tubular cells) or 22 h (for hepatocytes), later, [1251]-
deoxyuridine (final concentration; 37 kBq/ml) was added 
to the cells and the culture was continued for 4 h at 37 °C. 
Then, the incorporation of [1251]-deoxyuridine into DNA 
was measured by a gamma counter.
Assay of NAG activity. 
  NAG is a lysosomal enzyme present in renal tubular 
epithelial cells. It is released into conditioned medium 
when cultured tubular cells are damaged. NAG activity in 
the conditioned medium obtaine from primary cultured 
tubular cells incubated with or without 10 ,u M of FK506 
for 24 h was measured using the assay kit, NAG test 
Shionogi (Shionogi Pharmaceuticals, Osaka, Japan). 
Assay of GOT activity. 
  GOT is present in parenchymal hepatocytes and released 
into conditioned medium when cultured hepatocytes are 
damaged. GOT activity in the conditioned medium from 
primary cultured parenchymal hepatocytes incubated with 
or without 10 ,u M of FK506 for 24 h was measured using 
the assay kit, GOT-UV test Wako (Wako Pure Chemicals, 
Osaka, Japan). 
Assay of TGF- /3 activity in the medium conditioned by 
primary cultured rabbit renal cortical tubular cells and rat 
parenchymal hepatocytes. 
 TGF- /3 activity was determined based on inhibition of 
the DNA synthesis of cultured rat hepatocytes and was 
confirmed by the neutralization of the activity using 
specific antibody against TGF- /3 1 and -,8 2 (R & D 
systems, Minneapolis, MN) as described elsewhere'). When 
tubular cells grew subconfluently, the medium was 
changed to fresh basal medium and incubated with or 
without FK506 in a C02 incubator at 37 °C for 12 h. The 
cells were then washed 5 times with fresh basal medium to 
remove FK506 and cultured in basal medium containing 0.1 
% bovine serum albumin. Twenty-f our hours later, the 
medium was collected and concentrated 50-f old with a 
Centricon 10 (Amicon, Danvers, MA). Aliquots of the 
concentrated conditioned medium were acidified with 0.5 
M HCI at room temperature for 2 h, and neutralized with 
NaOH. TGF- /3 activity in the concentrated conditioned 
medium with or without acidification was assayed based
on inhibition of the DNA synthesis of rat hepatocytes 
stimulated with 10 ng/ml of human recombinant epider-
mal growth factor (EGF; Wakunaga Pharmaceuticals, 
Hiroshima, Japan) and 10-' M bovine insulin (Sigma 
Chemical Company, St. Louis, MO). To confirm this 
activity as TGF- /3 , aliquots of concentrated conditioned 
media or native human TGF- /3 1 obtained from King 
Brewering, Kakogawa, Japan were incubated with anti-T 
GF- /3 antibody at 37 °C for 1 h and added to cultured 
hepatocytes. DNA synthesis was then measured. To collect 
the medium conditioned by rat hepatocytes, freshly 
isolated hepatocytes were inoculated into a 100 mm dish 
coated by type I collagen and cultured for 24 h at 37 °C. 
After being washed, the cells were incubated with 
Williams' E medium supplemented with 5 U/ml of 
aprotinin and 0.1 % (W/VO) bovine serum albumin with 
or without 10 j M FK506. After 12 h-incubation, the cells 
were washed and cutured in Williams' E medium contain-
ing 5 U/ml aprotinin and 0.1 % bovine serum albumin. 
Twenty-four hours later, the medium was collected and 
treated as in the case of tubular cells.
RESULTS 
 Fig. 1 shows the effect of FK506 on the DNA synthesis 
of primary cultured rat parenchymal hepatocytes. FK506 
inhibited the DNA synthesis of hepatocvtes dose-
dependently with or without insulin and EGF. At 10 ,u M, 
FK506 caused no morphological changes in cultured 
hepatocytes and the suppression of DNA synthesis of 
hepatocytes was not cytotoxic sinse there was no increase
Fig. 1. Effects of FK506 on the DNA synthesis of adult rat 
hepatocytes in primary culture. FK506 with or without 10-'M 
of insulin and 10 ng/ml EGF were added to the cells and the 
incorporation of iododeoxyuridine was measured as de-
scribed in "Materials and Methods". Values are means for 
triplicate experiments.
Table 1. Release of enzyme from cultured parenchymal 
hepatocytes and renal cortical tubular cells.
( I ) Hepatocytes (n=3) 
  FK506( ,u M) GOT(IU/1 X 10' cells) 
      0 2.57± 0.33 
      1 3.03± 0.31 
     10 2.77± 0.98
(II) Tubular cells (n= 5) 
   FK506( ,a M) NAG(U/1 X 106 cells) 
      0 2.83± 2.15 
     10 1.16± 0.98
Experimental conditions are as described in "Materials and 
Methods". Values are expressed as means± SD.
Table 2. Effects of anti TGF- /3 antibody on medium condi-
tioned by cultured rat hepatocytes.
Addition DNA synthesis of 
                              hepatocytes (cpm)
none 2432± 156 
I + E 20831± 1234 
I + E + control lgG 22317± 1956 
I + E + anti TGF- /3 21543± 2021 
I + E + hTGF- /3 2020± 235 
I + E + hTGF- /3 + control lgG 2220± 216 
I + E + hTGF- /3 + anti TGF- /3 18572± 895 
I + E + acid-CM 3032± 455 
I + E + acid-CM + control lgG 2906± 180 
I + E + acid-CM + anti TGF- /3 19183± 1033
Fig. 2. Effects of the medium conditioned by rat hepatocytes 
treated with or without FK506 on the DNA synthesis of 
cultured rat hepatocytes stimulated by 10 -' M insulin and 10 
ng/ml EGF. Experimental conditions are as described in 
"Materials and Methods" . Open circle, non-treated condi-
tioned medium; closed circle, acidified conditioned medium; 
dotted line, basal DNA synthesis. Values are expressed as 
means for triplicate experiments.
Experimental conditions are as described in "Materials and 
Methods". I, insulin 10 ' M; E, EGF 10 ng/ml; control lgG, 
non-immune rabbit 1gG 50 mg/ ml; anti TGF- /3 , anti TGF-
/3 rabbit lgG 50 ,u g/ml; hTGF- /3 , human TGF- /3 11 ng/ml; 
acid-CM, 20% (Vo/Vo) of acidified and then neutralized 
conditioned medium. Values are means ± SD for triplicate 
experiments.
in the release of GOT in the medium (Table 1). TGF-13 is 
a potent growth inhibitor of cultured hepatocytes 10). The 
effect fo FK506 on the secretion of TGF- /3 activity by 
cultured hepatocytes was investigated. Conditioned me-
dium was collected after washing and the removal of 
FK506 because of its inhibitory effect on the DNA synthe-
sis of hepatocytes. Fig. 2 shows the acidified medium 
conditioned by rat hepatocytes to inhibit the DNA synthe-
sis of hepatocytes dose-dependently. To confirm this 
inhibitory effect of acidified conditioned medium, the 
effect of anti-TGF- /3 antibody on the activity was investi-
gated. The inhibitory activity was noted bo be neutralized 
by the specific antibody against TGF- a (Table 2). This 
indicates that the inhibition of DNA synthesis of 
hepatocytes is due to TGF- /3 activity and not to
Fig. 3. Effects of FK506 and HgCl2 on the DNA synthesis of 
cultured rabbit renal cortical tubular cells. FK506 and 
HgCI2 with or without 10 ng/ml EGF were added to the cells 
and the incorporation of iododeoxyuridine was measured as 
described in "Materials and Methods". Open circle, HgCl2; 
closed circle, FK506. Values are means for triplicate experi-
ments.
contamination by FK506. Parenchymal hepatocytes secret 
TGF-beta activity in a latent form and the amount of the 
activity was not changed with or without FK506 treat-
ment. 
 The effects of FK506 and HgCl2, which is known to cause 
ATN 2), on the DNA synthesis of cultured rabbit renal 
cortical tubular cells were studied. Fig. 3 shows that 
FK506 inhibits the DNA synthesis of tubular cells only at
conditioned medium on the DNA synthesis of cultured 
tubular cells in the case of acidification. This activity was 
also neutralized by anti-TGF- /3 antibody (data not 
shown). Secreted TGF- /3 activity appeared latent, as 
reported previously"). No obvious alteration in the 
amount of secreted both latent and active form TGF- (3 
activity could be detected. It has been reported that 
endothelin-1 (ET-1) is secreted by cultured tubular cells 
following stimulation with FK5066). To determine whether 
ET-1 is an autocrine growth stimulating factor, the effect 
of ET-1 on the DNA synthesis of cultured tubular cells was 
investigated. ET-1 had no effect on the DNA synthesis of 
cultured tubular cells with or without insulin and EGF 
(Table 3).
Fig. 4. Effects of the medium conditioned by renal tubular 
cells treated with or without FK506 on the DNA synthesis of 
cultured rat hepatocytes stimulated by 10 -' M insulin and 10 
ng/ml EGF. Experimental conditions are as described in 
"Materials and Methods" . Open circle, non-treated condi-
tioned medium; closed circle, acidified conditioned medium; 
dotted line, basal DNA synthesis. Values are expressed as 
means for triplicate experiments.
a high concentration (10 ,u M). But no remarkable effect 
of HgC12 was observed at the same concentration and the 
inhibitory potency of FK506 appeared more strong than 
that of HgC12. FK506 affects no morphological change in 
cultured tubular cells at 10 ,u M and had no cytotoxic 
effect at the same concentration (Table 1). The effect of 
FK506 on the secretion of TGF- /3 activity by cultured 
tubular cells was investigated. To assess TGF- /3 activity, 
we used cultured hepatocytes whose growth is inhibited by 
FK506. The medium conditioned by tubular cells used 
following incubation with FK506, and the removal of 
FK506 was used. Fig. 4 shows the inhibitory effect of the
Table 3. Effects of endothelin-1 (ET-1) on the DNA synthesis 
of cultured rabbit renal cortical tubular cells.
Addition DNA synthesis(cpm) 
none 973±2 
I + E 4397±100 
ET-1 10M 1005±14 
ET-1 10 -9 M 1021±35 
ET-1 10 -8 M 994±23 
ET-1 10.7 M 1038±51 
I +E + ET-1 10 -'0 M 4332±26 
I +E + ET-1 10 M 4118±45 
I +E + ET-1 10"M 3990±88 
I +E + ET-1 10.7 M 4250±74
Human endothelin-1 (Peptide Institute Inc., Minoh, Japan) 
was added to cultured rabbit renal cortical tubular cells and 
the DNA synthesis was measured as described in "Materials 
and Methods". Values are expressed as means ± SD for 
triplicate experiments.
DISCUSSION 
 FK506 at high concentration inhibited the DNA synthe-
sis of freshly isolated tubular cells and parenchymal 
hepatocytes in culture, but the effect was not cytotoxic. 
The inhibitory effect of FK506 on the growth of 
hepatocytes was more potent than that on tubular cell 
growth, and that on the tubular cell growth, more potent 
than that of HgClL. The concentration of blood FK506 at 
the concentration in clinical use is usually less than 0.1 
,u M 12). The regeneration and hyperplasia of renal tubular 
cells or parenchymal hepatocytes apparently is not inhib-
ited by FK506 at this concentration. 
 Rao et al.") reported mRNA of TGF- /3 to increase after 
FK506 administration in vivo, but no increase of TGF- /3 
activity secreted in the medium conditioed by parenchymal 
hepatocytes or tubular cells was observed in this study. 
Total cellular mRNA used in their study contained mRNA 
from non-parenchymal liver cells and increase in TGF- /3 
mRNA may have been caused by non-parenchymal cells. 
Sakr et al. 14) found FK506 to prevent renal ischemia/ 
reperfusion injury. This may have been due to inhibition of 
the production of tumor necrosis factor by FK506. But no 
growth stimulatory or inhibitory effect of the tumor 
necrosis factor on the growth of cultured renal tubular 
cells was observed 16). Moutabarrik et al'). reported that 
cultured tubular cells produce ET-1 in responce to FK506. 
But ET-1 has no effect on the growth of tubular cells. It is 
thus apparent that growth inhibition of FK506 is not 
mediated by known cytokines such as TGF- /3 , tumor 
necrosis factor, or ET-1. 
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